Cargando…

Individual vulnerabilities to psychosis after antiepileptic drug administration

BACKGROUND: Psychosis often develops after the administration of antiepileptic drugs (AEDs) in patients with epilepsy. However, the individual vulnerability and clinical condition of such patients have been rarely scrutinised. We investigated the effect of individually consistent (trait-dependent) a...

Descripción completa

Detalles Bibliográficos
Autores principales: Akanuma, Nozomi, Adachi, Naoto, Fenwick, Peter, Ito, Masumi, Okazaki, Mitsutoshi, Hara, Koichiro, Ishii, Ryouhei, Sekimoto, Masanori, Kato, Masaaki, Onuma, Teiichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7903174/
https://www.ncbi.nlm.nih.gov/pubmed/33681791
http://dx.doi.org/10.1136/bmjno-2019-000036
_version_ 1783654683819114496
author Akanuma, Nozomi
Adachi, Naoto
Fenwick, Peter
Ito, Masumi
Okazaki, Mitsutoshi
Hara, Koichiro
Ishii, Ryouhei
Sekimoto, Masanori
Kato, Masaaki
Onuma, Teiichi
author_facet Akanuma, Nozomi
Adachi, Naoto
Fenwick, Peter
Ito, Masumi
Okazaki, Mitsutoshi
Hara, Koichiro
Ishii, Ryouhei
Sekimoto, Masanori
Kato, Masaaki
Onuma, Teiichi
author_sort Akanuma, Nozomi
collection PubMed
description BACKGROUND: Psychosis often develops after the administration of antiepileptic drugs (AEDs) in patients with epilepsy. However, the individual vulnerability and clinical condition of such patients have been rarely scrutinised. We investigated the effect of individually consistent (trait-dependent) and inconsistent (state-dependent) characteristics. METHODS: The individual characteristics, clinical states and psychotic outcome of patients from eight adult epilepsy clinics were retrospectively reviewed over 6-month periods after a new drug (AED or non-AED) administration between 1981 and 2015. RESULTS: A total of 5018 new drugs (4402 AEDs and 616 non-AEDs) were used in 2015 patients with focal epilepsy. Subsequently, 105 psychotic episodes (81 interictal and 24 postictal) occurred in 89 patients. Twelve patients exhibited multiple episodes after different AED administrations. Trait-dependent characteristics (early onset of epilepsy, known presumed causes of epilepsy, lower intellectual function and a family history of psychosis) were significantly associated with the patients who exhibited psychosis. Absence of family history of epilepsy was also associated with psychosis but not significantly. Subsequent logistic regression analysis with a model incorporating family history of psychosis and epilepsy, and intellectual function was the most appropriate (p=0.000). State-dependent characteristics, including previous psychotic history and epilepsy-related variables (longer duration of epilepsy, AED administration, higher seizure frequency and concomitant use of AEDs) were significantly associated with psychotic episodes. Subsequent analysis found that a model including AED administration and previous psychotic history was the most appropriate (p=0.000). CONCLUSION: Psychosis occurring after new AED administration was related to the individual vulnerability to psychosis and intractability of epilepsy.
format Online
Article
Text
id pubmed-7903174
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-79031742021-03-04 Individual vulnerabilities to psychosis after antiepileptic drug administration Akanuma, Nozomi Adachi, Naoto Fenwick, Peter Ito, Masumi Okazaki, Mitsutoshi Hara, Koichiro Ishii, Ryouhei Sekimoto, Masanori Kato, Masaaki Onuma, Teiichi BMJ Neurol Open Original Research BACKGROUND: Psychosis often develops after the administration of antiepileptic drugs (AEDs) in patients with epilepsy. However, the individual vulnerability and clinical condition of such patients have been rarely scrutinised. We investigated the effect of individually consistent (trait-dependent) and inconsistent (state-dependent) characteristics. METHODS: The individual characteristics, clinical states and psychotic outcome of patients from eight adult epilepsy clinics were retrospectively reviewed over 6-month periods after a new drug (AED or non-AED) administration between 1981 and 2015. RESULTS: A total of 5018 new drugs (4402 AEDs and 616 non-AEDs) were used in 2015 patients with focal epilepsy. Subsequently, 105 psychotic episodes (81 interictal and 24 postictal) occurred in 89 patients. Twelve patients exhibited multiple episodes after different AED administrations. Trait-dependent characteristics (early onset of epilepsy, known presumed causes of epilepsy, lower intellectual function and a family history of psychosis) were significantly associated with the patients who exhibited psychosis. Absence of family history of epilepsy was also associated with psychosis but not significantly. Subsequent logistic regression analysis with a model incorporating family history of psychosis and epilepsy, and intellectual function was the most appropriate (p=0.000). State-dependent characteristics, including previous psychotic history and epilepsy-related variables (longer duration of epilepsy, AED administration, higher seizure frequency and concomitant use of AEDs) were significantly associated with psychotic episodes. Subsequent analysis found that a model including AED administration and previous psychotic history was the most appropriate (p=0.000). CONCLUSION: Psychosis occurring after new AED administration was related to the individual vulnerability to psychosis and intractability of epilepsy. BMJ Publishing Group 2020-08-27 /pmc/articles/PMC7903174/ /pubmed/33681791 http://dx.doi.org/10.1136/bmjno-2019-000036 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Original Research
Akanuma, Nozomi
Adachi, Naoto
Fenwick, Peter
Ito, Masumi
Okazaki, Mitsutoshi
Hara, Koichiro
Ishii, Ryouhei
Sekimoto, Masanori
Kato, Masaaki
Onuma, Teiichi
Individual vulnerabilities to psychosis after antiepileptic drug administration
title Individual vulnerabilities to psychosis after antiepileptic drug administration
title_full Individual vulnerabilities to psychosis after antiepileptic drug administration
title_fullStr Individual vulnerabilities to psychosis after antiepileptic drug administration
title_full_unstemmed Individual vulnerabilities to psychosis after antiepileptic drug administration
title_short Individual vulnerabilities to psychosis after antiepileptic drug administration
title_sort individual vulnerabilities to psychosis after antiepileptic drug administration
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7903174/
https://www.ncbi.nlm.nih.gov/pubmed/33681791
http://dx.doi.org/10.1136/bmjno-2019-000036
work_keys_str_mv AT akanumanozomi individualvulnerabilitiestopsychosisafterantiepilepticdrugadministration
AT adachinaoto individualvulnerabilitiestopsychosisafterantiepilepticdrugadministration
AT fenwickpeter individualvulnerabilitiestopsychosisafterantiepilepticdrugadministration
AT itomasumi individualvulnerabilitiestopsychosisafterantiepilepticdrugadministration
AT okazakimitsutoshi individualvulnerabilitiestopsychosisafterantiepilepticdrugadministration
AT harakoichiro individualvulnerabilitiestopsychosisafterantiepilepticdrugadministration
AT ishiiryouhei individualvulnerabilitiestopsychosisafterantiepilepticdrugadministration
AT sekimotomasanori individualvulnerabilitiestopsychosisafterantiepilepticdrugadministration
AT katomasaaki individualvulnerabilitiestopsychosisafterantiepilepticdrugadministration
AT onumateiichi individualvulnerabilitiestopsychosisafterantiepilepticdrugadministration